Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024
... a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other ... Read More
-
Global Clinical Trial Supply and Logistic for Pharmaceutical Competitive Landscape Professional Research Report 2024
... used in clinical trials. This process ensures that the right quantity of trial supplies is available at the right time and in the right condition at various study sites globally. It involves careful planning, forecasting, ... Read More
-
Lateral Flow Assay Components Market Assessment, By Component Type [Membranes, Pads, Others], By Application Type [Clinical Testing, Veterinary Testing, Food Safety and Environmental Testing, Drug Development and Quality Testing, Others], By Technique Type [Sandwich Assays, Multiplex-Detection Assays, Competitive Assays], By End-user [Hospitals, Diagnostic Laboratories, Home-Care Settings, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F
... Multiplex-Detection Assays, Competitive Assays], By End-user [Hospitals, Diagnostic Laboratories, Home-Care Settings, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F Global lateral flow assay components market is projected to witness ... Read More
-
Hydroxychloroquine Market Size, Trends, Analysis, and Outlook By Product (Tablet, Active Pharmaceutical Ingredients), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Drug Store), By Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, Others), by Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Hydroxychloroquine market size is poised to register a 7.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The Hydroxychloroquine market study ... Read More
-
Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 7.42 billion in 2024, at a CAGR 18.91% to reach USD 21.01 billion by 2030. Computational biology is an interdisciplinary domain that applies techniques from computer science, applied mathematics, ... Read More
-
Endocrinology Drugs Market by Therapy Area (Diabetes Drugs, Human Growth Hormone, Thyroid Hormone Disorders), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies) - Global Forecast 2024-2030
... 32.78 billion in 2023 and expected to reach USD 35.05 billion in 2024, at a CAGR 7.34% to reach USD 53.85 billion by 2030. Endocrinology drugs are medications that are used to treat disorders of ... Read More
-
Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 5.14 billion in 2024, at a CAGR 9.95% to reach USD 9.09 billion by 2030. Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat ... Read More
-
Albumin Market by Source (Animal Sources, Plant Sources), Type (Non-Recombinant, Recombinant), Application, End User - Global Forecast 2024-2030
... 6.94 billion in 2024, at a CAGR 6.61% to reach USD 10.23 billion by 2030. Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. ... Read More
-
Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030. The market for research antibodies refers to the global industry that revolves around ... Read More
-
RNA Interference Technology Market by Type (dsRNA, miRNA, siRNA), Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders), Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030. The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules ... Read More
-
Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Global Forecast 2024-2030
... to reach USD 7.80 billion in 2024, at a CAGR 8.98% to reach USD 13.09 billion by 2030. Dysmenorrhea treatment refers to the therapeutic approaches for managing and alleviating the pain and discomfort associated with ... Read More
-
Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030
... USD 620.68 billion in 2023 and expected to reach USD 672.44 billion in 2024, at a CAGR 8.66% to reach USD 1,110.17 billion by 2030. Pharmaceutical manufacturing comprises research, development, production, marketing, and distribution of ... Read More
-
Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), End-User, Application - Global Forecast 2024-2030
... 4.40 billion in 2024, at a CAGR 14.55% to reach USD 9.87 billion by 2030. Biosimulation combines mathematics, biology, and computer programming to create simulations to test hypotheses, predict outcomes, and explore new possibilities in ... Read More
-
Global anal fissure therapeutics market - 2024-2031
... period 2024-2031. An anorectal condition marked by inflammation or tearing of the lining of the lower rectum is known as an anal fissure. During bowel movements, it causes considerable discomfort and blood. The ailment is ... Read More
-
Familial Adenomatous Polyposis Treatment Market by Type (Aspirin, CEQ-508, Eflornithine Hydrochloride), End-Users (Clinics & Hospitals, Diagnostic Centres, Home Healthcare), Distribution Channel - Global Forecast 2024-2030
... USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.43% to reach USD 1.85 billion by 2030. Familial Adenomatous Polyposis (FAP) treatment refers to the medical interventions ... Read More
-
Devic's Syndrome Treatment Market by Treatment (Corticosteroids, Immunosuppressants, Plasma Exchange (Plasmapheresis)), Distribution Channel (Clinics, Hospitals, Online Pharmacies), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 220.27 million in 2024, at a CAGR 4.68% to reach USD 290.03 million by 2030. Devic's Syndrome, also known as neuromyelitis optica (NMO), is a chronic disorder of ... Read More
-
Infertility Drugs & Devices Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High cost of treatment A single ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of therapeutic ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
Tumor Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tumor Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Technology (Microarray, Real-Time Quantitative, Polymerase Chain Reaction (Q-PCR), Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F
... Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F Global Tumor ... Read More
-
Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis and Latent Tuberculosis), By Therapy (First Line Therapy and Second Line Therapy), By Region, Competition, Forecast and Opportunities, 2019-2029F
... USD 25.48 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.12% through 2029. The Vietnam Tuberculosis Therapeutics Market is primarily driven by several key factors ... Read More
-
Amyotrophic Lateral Sclerosis- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Acid sphingomyelinase deficiency (ASMD) – Market Insight, Epidemiology, and Market Forecast – 2034
... sphingomyelinase deficiency (ASMD), historical and forecasted epidemiology as well as the Acid sphingomyelinase deficiency (ASMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acid sphingomyelinase deficiency ... Read More
Research Assistance
